Ahead of the Bell: Achillion Pharma shares slide


Hepatitis c drugs has become a major research field, because it is a chronic disease, more cases, is expected to be diagnosed as baby boomers age. Companies are racing to develop new and more convenient treatment.
New haven, Connecticut, the company said on Monday that shortly after the market closed, the food and drug administration (fda) research on clinical keep after several subjects, the researchers found that an elevated liver enzymes.
YiQiEr research, when the researchers tested the unexpected elevation, and management booster atazanivir sovaprevir, stops, the combination of management, and contact with the FDA.
The U.S. food and drug administration has asked the ongoing sovaprevir study some drug interactions and safety analysis report. Said it expects YiQiEr to offer the information about six weeks.
At the same time, regulators will sovaprevir allow continue to recruit students at the intermediate stage research and treatment.
, currently YiQiEr research three potential in patients with chronic hepatitis c, sovaprevir is one of the most advanced. The company is expected in the third quarter, some results of the study.
Hepatitis c is a virus that can lead to life-threatening liver damage, liver transplantation in the United States is the main reason. The disease is spread through blood, and can be Shared intravenous drug needles with an infected person or have sex. It can not be found many years until the liver was seriously damaged.
Sinking YiQiEr shares more than 23%, or $1.98 to $6.38 in pre-market trading on Tuesday, about 90 minutes, ahead of market opening. Its shares trading at 52-week range $5.42 $11.36.

<>Ahead of the Bell: Achillion Pharma shares slide

bearing warehouse


 


PREVIOUS:Rothschild to advise on potential RBS split        NEXT:Norwegian posts Q2 jump in sales, earnings

ADD:Room 1701,17/F,HENAN BUILDING,NO.90 JAFFE ROAD,WANCHAI HONGKONG
TANCHIN INTERNATIONAL INDUSTRIES Co.,Ltd


ADD:152 BEACH ROAD,#14-03,GATEWAY EAST, SINGAPORE 189721
TANCHIN INDUSTRIES PTE. Ltd

  • Exchange links